Sartorius to invest $3m for minority share in biotech start-up Nanotein
Nanotein’s NanoSpark reagents improve cell activation and expansion in cell therapy manufacturing.
Cytiva Navigating cell therapy WP 4
ViroCell and AvenCell to advance allogeneic CAR-T therapy manufacture
UK enacts law to decentralise manufacture of personalised treatments
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
DoH and Children’s National Hospital link for cell and gene therapy
AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline
FDA removes safety programme for CAR-T therapies to boost uptake
FDA approves label updates for BMS’ CAR T cell therapies
